Veracyte

We are developing molecular tests designed to improve the diagnostic accuracy of cytology samples, thereby helping to increase the utility of these minimally invasive procedures as an alternative to surgical biopsy. Our Goal: Enable Doctors to Make More Informed Treatment Decisions Our Focus: Molecular Cytology
Type
Public
HQ
South San Francisco, US
Founded
2008
Employees
192 (est)+15%
Veracyte was founded in 2008 and is headquartered in South San Francisco, US

Key People at Veracyte

Richard Lanman

Richard Lanman

Chief Medical Officer
Chris Hall

Chris Hall

Chief Commercial Officer
Shelly D. Guyer

Shelly D. Guyer

CFO
Bonnie Anderson

Bonnie Anderson

Co-Founder & CEO
Robert Monroe

Robert Monroe

VP, Laboratory Operations & Medical Director
Giulia C. Kennedy

Giulia C. Kennedy

Chief Scientific Officer

Veracyte Locations

South San Francisco, US
Austin, US

Veracyte Metrics

Veracyte Summary

Market capitalization

$213 M

Closing share price

$7.71
Veracyte's latest market capitalization is $213 M.

Veracyte Market Value History

Veracyte Company Life